InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Wednesday, 02/21/2018 6:30:24 AM

Wednesday, February 21, 2018 6:30:24 AM

Post# of 807
From LSE. Nice to hear

Today 09:59
JonTaylor
Oxb
11.96
Strong Buy
My son is a recipient of the CAR-T cell therapy for acute lymphoblastic leukaemia - and I'm also a modest shareholder in this company. So you could say on both counts I have a vested interest in the share price and technology behind it!
If it helps anyone out there deciding whether to stay in or out - I can tell you that for my son the treatment is working. Good luck to all !